Minimal Residual Disease by Flow Cytometry and Allelic-Specific Oligonucleotide Real-Time Quantitative Polymerase Chain Reaction in Patients With Myeloma Receiving Lenalidomide Maintenance: A Pooled Analysis
Cancer - United States
doi 10.1002/cncr.31854
Full Text
Open PDFAbstract
Available in full text
Date
December 18, 2018
Authors
Publisher
Wiley